Condiciones de salud que Cardo mariano puede ayudar a apoyar.
Milk thistle has centuries of traditional use for upper gastrointestinal and digestive complaints. A PMC review confirms it has been used as a natural treatment for upper GI tract and digestive problems. Mayo Clinic notes that milk thistle in combination with other supplements may improve symptoms of indigestion (dyspepsia). The German Commission E has also recognized its traditional gastrointestinal applications.
Clinical evidence supports topical and oral silymarin for acne. A trial of 0.5% silymarin serum applied twice daily for 4 weeks reduced sebum secretion, lesion count, pigmentation, and erythema. A separate study found oral silybin over 8 weeks significantly reduced acne signs, with results comparable to doxycycline.
Milk thistle's active complex, silymarin, has well-documented antioxidant mechanisms supported by both laboratory research and human clinical data. It directly scavenges free radicals, inhibits lipid peroxidation, elevates intracellular glutathione, and upregulates endogenous antioxidant enzymes via Nrf2 activation. Clinical studies in chronic liver disease populations confirm enhancement of measurable antioxidant defense markers, though overall evidence quality is rated low-to-moderate due to trial heterogeneity and small sample sizes.
Multiple RCTs and meta-analyses show silymarin reduces fasting blood glucose and HbA1c in type 2 diabetes patients. A meta-analysis of 7 studies (370 patients) found silymarin decreased fasting glucose by ~38 mg/dL and HbA1c by ~1.4%. A second meta-analysis of 16 studies (1,358 patients) confirmed reductions in fasting glucose, HbA1c, and LDL cholesterol.
Meta-analyses of RCTs consistently show silymarin reduces total cholesterol, LDL cholesterol, and fasting glucose in diabetic and metabolic syndrome populations. A Merck Manual-cited meta-analysis of 16 RCTs (1,358 patients) confirmed reductions in total cholesterol and LDL. A 2021 ScienceDirect meta-analysis found LDL-C reduction with silymarin but no significant effect on total cholesterol or triglycerides in all studies.
Milk thistle's active constituent, silymarin, has human clinical evidence supporting a modest anti-inflammatory effect. Multiple RCTs and meta-analyses demonstrate statistically significant reductions in circulating inflammatory markers—particularly CRP and IL-6—in adults across conditions characterized by chronic inflammation (NAFLD, diabetes, thalassemia). The mechanistic basis is well-characterized at the molecular level, though overall evidence strength is moderate and clinical translation remains incomplete.
Silymarin shows neuroprotective effects in multiple preclinical models and emerging human data. Animal studies demonstrate suppression of amyloid-β plaque formation and improvement in cognitive performance. A small 2020 human trial in adults with mild cognitive impairment reported improvements in memory and attention after 6 months of milk thistle extract supplementation.
Milk thistle (Silybum marianum), through its active complex silymarin, has shown positive results in a small placebo-controlled clinical trial in ulcerative colitis patients. Silymarin suppresses NF-κB-mediated inflammation and reduces TNF-α and IL-1β in bowel tissue. A registered clinical trial is ongoing to confirm its efficacy as adjunct therapy in UC.
Milk thistle (Silybum marianum) contains silymarin, a flavonoid complex that protects hepatocytes from damage caused by environmental toxins (heavy metals, alcohol, acetaminophen, carbon tetrachloride, pesticides) by scavenging free radicals, enhancing glutathione levels, inhibiting lipid peroxidation, and modulating cytochrome P450 and phase II detoxification enzymes.
Silymarin from milk thistle (Silybum marianum) reduces biliary cholesterol concentration and improves the bile salt-to-cholesterol ratio, reducing gallstone-forming potential. A 3-month clinical study in cholesterol gallstone patients showed significantly reduced bile lithogenicity. Combined with artichoke and green tea (150 mg each), it resolved or reduced biliary sludge in 64% of patients in a 2024 open-label study.
Silymarin (from Milk Thistle, Silybum marianum) has been used for centuries as a natural remedy for diseases of the liver and biliary tract, as documented in an AHRQ-commissioned systematic review (NCBI Bookshelf). Silymarin exhibits choleretic properties, stimulates bile production, and in animal models reduces cholesterol output in bile while expanding the bile acid pool. A combination study including milk thistle (150 mg), artichoke, and green tea showed significant reduction in biliary sludge and biliary colic over 3 months.
Milk thistle's active silymarin complex, particularly silybin, is a confirmed mixed-type xanthine oxidase inhibitor in vitro that also reduces XO-generated superoxide. Animal studies from 2013 and 2016 found milk thistle extract may lower uric acid in rats with health conditions damaging the kidneys. The 2023 Food Frontiers review ranked silybin among flavonoids that decrease uric acid in hyperuricemic animals by more than 50% at certain doses.
Milk thistle (Silybum marianum) contains silymarin, a flavonolignan complex with potent hepatoprotective and antioxidant effects. Its relevance to healthy aging centers on liver protection against age-related hepatic decline and oxidative damage. Silymarin also activates Nrf2 and has demonstrated anti-aging effects in model organisms, with clinical trials supporting hepatic function in older adults.
Milk thistle (Silybum marianum), via its active flavonolignan complex silymarin, protects the liver from toxin-induced damage and restores depleted glutathione levels—a critical endogenous metal chelator. It is used as a hepatoprotective adjunct in heavy metal detox protocols. Evidence from human RCTs supports liver enzyme normalization; direct metal chelation evidence is limited.
Milk thistle (Silybum marianum) has been used for over 2,000 years as a hepatoprotective remedy. Its active compound silymarin stimulates Phase II detoxification pathways, upregulates liver detox enzymes, and can modulate estrogen receptor activity. The NCI documents that silymarin stabilizes cellular membranes and stimulates detoxification pathways relevant to hormone clearance.
Milk thistle (Silybum marianum) contains silymarin, which inhibits melanogenesis and has been evaluated in four clinical studies for melasma identified in a 2023 systematic meta-analysis. It is recognized as a naturally occurring depigmenting agent in multiple dermatological reviews.
Silymarin, the active flavonolignan complex from Milk Thistle (Silybum marianum), has insulin-sensitizing properties and the NIH Endotext lists it as an insulin sensitizer studied in patients with diabetes. Clinical trials in T2DM and NAFLD patients show reductions in fasting glucose, HbA1c, and insulin resistance markers.
Milk thistle (Silybum marianum) and its active flavonolignan complex silymarin have documented nephroprotective properties beyond their well-known liver benefits. Clinical trials demonstrate that silymarin protects against nephrotoxicity from agents such as cisplatin (chemotherapy) and cyclosporine. Animal studies show silymarin reduces proteinuria and alleviates renal tissue damage in diabetic models, and adding it to renin-angiotensin system inhibitors significantly reduced urinary albumin excretion in diabetic nephropathy patients.
Milk thistle (Silybum marianum) and its active extract silymarin have centuries of traditional use for hepatic disorders. Clinical trials show silymarin modestly reduces liver enzyme markers (ALT, AST) and oxidative stress in alcoholic and non-alcoholic liver disease. A pooled analysis of trials in cirrhosis patients found silymarin associated with a significant reduction in liver-related deaths. Evidence is promising but mixed due to small, heterogeneous trials.
Milk thistle (Silybum marianum) and its primary extract silymarin have been studied in multiple human randomized controlled trials and meta-analyses for core components of metabolic syndrome, including insulin resistance, dyslipidemia, hyperglycemia, and non-alcoholic fatty liver disease (NAFLD). A 2020 meta-analysis of 16 RCTs (1,358 patients) found silymarin supplementation significantly reduced fasting blood glucose, HOMA-IR, and triglycerides while improving HDL-C. A separate meta-analysis in type 2 diabetes (5 RCTs, 270 patients) found significant reductions in fasting glucose (−26.86 mg/dL) and HbA1c (−1.07%), though evidence quality is rated as low-to-moderate due to heterogeneity across trials. Clinical evidence supports biological plausibility, but large, well-designed trials focused specifically on metabolic syndrome as a composite endpoint remain limited.
Milk thistle (Silybum marianum) and its active constituent silymarin are among the most studied hepatoprotective agents for mycotoxin-induced liver injury. A 2023 PMC review found milk thistle seed and oil supplementation effective in preventing histopathological changes caused by dietary deoxynivalenol and zearalenone in ducks. A comprehensive 2023 PMC review confirmed its restoration of liver function, oxidative status, and immunity in mycotoxin-poisoned animals across multiple species.
Milk thistle's active constituent silymarin has shown anti-inflammatory effects against pancreatitis in preclinical models, attenuating cerulein-induced acute pancreatitis in mice by inhibiting p38 MAPK signaling and reducing oxidative stress, cytokines TNF-α and IL-6, and tissue damage. Small-scale clinical studies have reported symptom improvements in chronic pancreatitis patients. Traditional use includes recommendation for alcohol-related chronic pancreatitis.
Milk thistle (Silybum marianum) and its active component silymarin have demonstrated mechanisms relevant to PCOS, including lowering testosterone, increasing SHBG synthesis, inhibiting inflammation, and reducing blood glucose. It is identified in herbal medicine reviews as having documented reproductive endocrinological mechanisms in PCOS.
Silymarin (the active flavonolignan complex of Milk Thistle) has robust clinical evidence for hepatoprotective and liver-regenerating effects, directly relevant to post-illness liver recovery after hepatitis, drug-induced liver injury, or medication use. It has been used in European and Ayurvedic medicine for convalescence from liver-affecting illnesses.
Silymarin from milk thistle (Silybum marianum) reduced facial redness in 29/32 rosacea participants in an open-label trial with twice-daily topical cream over 12 weeks. Combined with MSM in a double-blind RCT (n=46), it significantly improved redness, papules, itching, and hydration versus placebo (P<0.001). Karger's 2026 rosacea review lists milk thistle with both preclinical and clinical data.
Silymarin's antioxidant and photoprotective properties have been investigated for reducing skin aging. Topical silymarin scavenges free radicals that degrade collagen and elastin, and studies in the Journal of Drugs in Dermatology highlight its ability to reduce oxidative stress—a key driver of skin aging. Photoprotection against UVA/UVB has been studied with visible effects at 8 weeks.
Milk thistle contains silymarin, which has been documented in multiple studies to inhibit UV-induced inflammation, oxidative stress, and photocarcinogenesis. It inhibits UVB-induced COX-2 expression and prostaglandin tumor promoters in skin, and is listed among the most promising photochemoprotective botanicals in authoritative phytochemistry reviews.
Milk thistle (Silybum marianum) and its active complex silymarin have been studied in RCTs and meta-analyses for lipid effects including triglyceride reduction, particularly in patients with fatty liver disease (NAFLD/NASH) and T2D. The combination of berberine with silymarin shows significant TG reduction in multiple RCTs.
Milk thistle's active extract silymarin has antioxidant, anti-inflammatory, and antifibrotic properties supporting liver detoxification. A 2023 systematic review of 29 RCTs (n=3,846) found 65.5% of studies reported reduced liver enzyme levels with silymarin. It has been used in Western herbalism for liver and gallbladder cleansing for centuries.
Milk thistle (Silybum marianum) is a traditional galactagogue included in proprietary lactation supplements. The NIH LactMed database notes that while no scientifically valid clinical trials support milk thistle itself as a galactagogue, a purified silymarin formulation with phosphatidylserine and goat's rue produced a large increase in milk volume on day 4 postpartum in one study. Animal studies have shown silymarin increases serum prolactin. A double-blind RCT in preterm infants' mothers found no significant milk volume benefit from a silymarin-phosphatidylserine product versus placebo.
Milk thistle (Silybum marianum) and its active silymarin complex are included in colon-cleanse formulas primarily for hepatoprotective and bile-stimulating (cholagogue) properties, which support the liver's detoxification role during colon cleansing. Traditional use spans over 2,000 years for liver and digestive conditions. Scientific evidence for liver protection is strong, though direct colon-cleansing evidence is traditional.
Milk thistle (Silybum marianum) is widely used in integrative Lyme disease protocols for hepatoprotective support, addressing liver stress from both Borrelia toxins and long-term antibiotic therapy. Silymarin (its active flavonolignan complex) has potent antioxidant and anti-inflammatory properties. Over 2,000 years of traditional use for liver protection, with clinical evidence supporting hepatoprotection in drug-induced liver injury applicable to Lyme antibiotic regimens.
Milk Thistle (Silybum marianum) contains silymarin, a hepatoprotective flavonolignan complex used traditionally and clinically to support liver recovery after viral hepatitis—a direct post-viral application. Commission E and ESCOP monographs support its use for toxic liver damage and as adjunct in chronic inflammatory liver conditions. Post-viral liver involvement in COVID-19 has been documented.
Milk thistle (Silymarin) has a long European and Mediterranean tradition of use as a galactagogue postpartum. A Cochrane review of oral galactagogues (27 studies, 962 participants) included silymarin (milk thistle) among studied galactagogues showing some benefit for milk volume. It is listed in the Moringa/galactagogue literature as a recognized traditional galactagogue.
Volver